GOLGA8F

Across TCGA pan-cancer cohorts, GOLGA8F RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GOLGA8F’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where GOLGA8F RNA is repressed in tumor relative to normal tissue. In most cancer types GOLGA8F is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

BRCA, THCA, and KIRC are the cancer types where GOLGA8F tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GOLGA8F RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.008	<.001	6	view →
THCA	All	All	−0.007	.015	2	view →
KIRC	Male	All	+0.004	.032	2	view →
KICH	All	All	−0.005	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

GOLGA8F–BRCA

Open the BRCA breakdown →